GLENMARK LIFE SCIENCES
Back to Balance Sheet
|
GLENMARK LIFE SCIENCES Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹439 Cr | ₹1,015 Cr | ₹747 Cr | ₹1,445 Cr | ₹1,307 Cr |
What is the latest Total Current Liabilities ratio of GLENMARK LIFE SCIENCES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹439 Cr |
Mar2023 | ₹1,015 Cr |
Mar2022 | ₹747 Cr |
Mar2021 | ₹1,445 Cr |
Mar2020 | ₹1,307 Cr |
How is Total Current Liabilities of GLENMARK LIFE SCIENCES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹439 Cr | -56.77 | |
Mar2023 | ₹1,015 Cr | 35.90 | |
Mar2022 | ₹747 Cr | -48.32 | |
Mar2021 | ₹1,445 Cr | 10.51 | |
Mar2020 | ₹1,307 Cr | - |
Compare Total Current Liabilities of peers of GLENMARK LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK LIFE SCIENCES | ₹13,067.1 Cr | -1.6% | 2.6% | 74.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,271.0 Cr | -0.9% | -4.8% | 50.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,183.0 Cr | 3% | 5.9% | 65% | Stock Analytics | |
CIPLA | ₹120,605.0 Cr | 1.5% | 0.1% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,869.0 Cr | -0.4% | -8.2% | 7.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,808.6 Cr | 0.6% | -5.3% | 51% | Stock Analytics |
GLENMARK LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK LIFE SCIENCES | -1.6% |
2.6% |
74.8% |
SENSEX | 3.5% |
-0.1% |
21.9% |
You may also like the below Video Courses